HCCS

Holocytochrome c-type synthase · P53701 · HCCS on Sugi Atlas →

0 patent compounds predicted against HCCS, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to HCCS by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma PHASE4UNKNOWN
Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy PHASE2COMPLETED
Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC) PHASE1/PHASE2WITHDRAWN
Resveratrol and Human Hepatocyte Function in Cancer PHASE1/PHASE2WITHDRAWN
Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma PHASE2COMPLETED
Branched-chain Amino Acid Supplementation for Hepatocellular Carcinoma PHASE2WITHDRAWN
Randomized Phase II Trial of Chemoembolization and Sorafenib PHASE2WITHDRAWN
Q-Trial in Patients With Hepatitis C PHASE1COMPLETED
A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma EARLY_PHASE1COMPLETED
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC) nanUNKNOWN
Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma nanUNKNOWN
Genes Involved in Resistance or Susceptibility to Hepatitis B Virus nanCOMPLETED
Identification and Prognostic Value of Key Genes in Hepatocellular Carcinoma nanUNKNOWN
VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway nanUNKNOWN
Biologic Basis of Liver Cancer From Chronic Hepatitis B nanCOMPLETED
Different Genetic Features Associated With Hepatic Carcinogenesis nanUNKNOWN
Sialic Acid in Hepatocellular Carcinoma nanNOT_YET_RECRUITING
Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases. nanRECRUITING
Genetic Studies in Liver Cancer Patients nanUNKNOWN
Serum Visfatin and Serum Vaspin in Patients With Hepatocellular Carcinoma on Top of Liver Cirrhosis nanCOMPLETED
MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali Patients nanUNKNOWN
Novel Biomarker Assay for Biomarker Assay for HCC Detection nanUNKNOWN
Long Term Prediction of MASH-related HCC Risk by Proteomics nanNOT_YET_RECRUITING
Detect and Expunge Concealed Tumors of the Liver nanACTIVE_NOT_RECRUITING
Role of Vitamin C Infusion in Postoperative Mechanically Ventilated Neonates With Sepsis nanCOMPLETED
Molecular Basis of Pediatric Liver Cancer nanRECRUITING
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis nanUNKNOWN
Screening for Hepatitis Virus B Protein X (HBx) in Colitis-associated Cancer (CAC) nanNOT_YET_RECRUITING
Serum Levels of Some Trace Elements in Hepatocellular Carcinoma Patients nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a HCCS binder may also engage these)

ProteinNameSimilarity
A5PJG7 1.000 A5PJG7 →
P53702 1.000 P53702 →
Q5F339 0.998 Q5F339 →
P53703 0.986 P53703 →
P14187 0.975 P14187 →
P53700 0.971 P53700 →
P9WES7 0.968 P9WES7 →
Q5R6F1 0.967 Q5R6F1 →
Q69ZX6 0.966 Q69ZX6 →
A1L243 0.966 A1L243 →
Q2UM19 0.966 Q2UM19 →
Q5U2R7 0.966 Q5U2R7 →
P06182 0.966 P06182 →
Q00873 0.965 Q00873 →
O13962 0.965 O13962 →
Q7SH49 0.964 Q7SH49 →
I1RMK9 0.964 I1RMK9 →
Q9LXT9 0.963 Q9LXT9 →
XPA DNA repair protein complementing XP-A cells 0.963 landscape →
Q5ZLM0 0.963 Q5ZLM0 →
B5DDX6 0.963 B5DDX6 →
Q04499 0.963 Q04499 →
Q681Q7 0.962 Q681Q7 →
CDC37 Hsp90 co-chaperone Cdc37 0.962 landscape →
METTL3 N6-adenosine-methyltransferase catalytic subunit 0.962 landscape →
Q8C3P7 0.962 Q8C3P7 →
SF3A1 Splicing factor 3A subunit 1 0.961 landscape →
Q3UJB0 0.961 Q3UJB0 →
Q4WN42 0.961 Q4WN42 →
Q552W5 0.961 Q552W5 →